Cancer therapy
It is still a pending issue for many “smart” nanocarriers endowed with a controlled and site-specific drug release mechanism to overcome the therapeutic efficacy and minimize therapy-associated side effects obtained by their older brothers, the golden benchmarked nonsensitive formulations.…
